Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-18-039717

President & CEO sold 130,000 shares at an average $49.52 ($6,438,036)

  • President & CEO acquired 130,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ROBIN HOWARD W President & CEO 2018-06-25 Option exercise +43,334 $10.69 $463,240 267,690 D
ROBIN HOWARD W President & CEO 2018-06-25 Sale −43,334 $51.82 $2,245,568 224,356 D
ROBIN HOWARD W President & CEO 2018-06-26 Option exercise +43,333 $10.69 $463,230 267,689 D
ROBIN HOWARD W President & CEO 2018-06-26 Sale −43,333 $49.36 $2,138,917 224,356 D
ROBIN HOWARD W President & CEO 2018-06-27 Option exercise +43,333 $10.69 $463,230 267,689 D
ROBIN HOWARD W President & CEO 2018-06-27 Sale −43,333 $47.39 $2,053,551 224,356 D
Derivatives
ROBIN HOWARD W President & CEO 2018-06-25 Option exercise · Stock Option −43,334 126,666 D
ROBIN HOWARD W President & CEO 2018-06-26 Option exercise · Stock Option −43,333 83,333 D
ROBIN HOWARD W President & CEO 2018-06-27 Option exercise · Stock Option −43,333 40,000 D
Open-market sales · 130,000 sh · avg $49.52 · $6,438,036
Loading xslF345X03/doc4.xml…